Molecular Therapy - Oncolytics : Impact Factor & More
eISSN: 2372-7705pISSN: 2372-7705
Open AccessShare this on:
Key Metrics
CiteScore 
6.7
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q3Oncology
SNIP
1.02
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Molecular Therapy - Oncolytics
Molecular Therapy - Oncolytics Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | CELL PRESS |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 3900 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | American Society for Gene and Cell Therapies |
| Frequency | Continuous publication |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Molecular Therapy - Oncolytics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Molecular Therapy - Oncolytics
Thank you to our 2023 reviewers
- 1 Dec 2023
- Molecular Therapy - Oncolytics
Gaining insights into virotherapy with canine models
- 1 Dec 2023
- Molecular Therapy - Oncolytics
Targeting mesothelin in cancer
- 1 Dec 2023
- Molecular Therapy - Oncolytics
MiR-146a: Overcoming coldness in ovarian cancer
- 1 Dec 2023
- Molecular Therapy - Oncolytics
New advances in cancer therapy targeting TGF-β signaling pathways
- 1 Dec 2023
- Molecular Therapy - Oncolytics
The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges
- 23 Nov 2023
- Molecular Therapy - Oncolytics
Thank you to our 2023 reviewers
- 1 Dec 2023
- Molecular Therapy - Oncolytics
Gaining insights into virotherapy with canine models
- 1 Dec 2023
- Molecular Therapy - Oncolytics
Targeting mesothelin in cancer
- 1 Dec 2023
- Molecular Therapy - Oncolytics
MiR-146a: Overcoming coldness in ovarian cancer
- 1 Dec 2023
- Molecular Therapy - Oncolytics
New advances in cancer therapy targeting TGF-β signaling pathways
- 1 Dec 2023
- Molecular Therapy - Oncolytics
The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges
- 23 Nov 2023
- Molecular Therapy - Oncolytics
FAQs on Molecular Therapy - Oncolytics
How long has Molecular Therapy - Oncolytics been actively publishing? 
What is the publishing frequency of Molecular Therapy - Oncolytics?
How many articles did Molecular Therapy - Oncolytics publish last year?
What is the eISSN & pISSN for Molecular Therapy - Oncolytics?
What is Citescore for Molecular Therapy - Oncolytics?
What is SNIP score for Molecular Therapy - Oncolytics?
What is the SJR for Molecular Therapy - Oncolytics?
Who is the publisher of Molecular Therapy - Oncolytics?
